Phase III trials aim to assess whether a new treatment has superior efficacy than a standard treatment. Sequential methods, such as the sequential probability ratio test (SPRT), the triangular test (TT) and so-called one-parameter boundaries (OPB), now allow early stopping of such trials, both in the case of efficacy (alternative hypothesis; H1) and in the case of lack of efficacy (null hypothesis; H0). We compared the statistical properties of the SPRT and the TT, and of OPB with Pocock (OPBΔ = 0.5) and O'Brien and Fleming (OPBΔ = 0) type boundaries, in the setting of one-sided comparative trials with normal response. We studied the type I error (α), power (1-β), average sample number (ASN) and 90th percentile (P90) of the number of patients required to reach a conclusion using simulations. The four tests were also compared with the corresponding single-stage design (SSD). All sequential tests display α and 1-β close to nominal values and, as compared with SSD, allow important decreases in ASN: for example, -48%, -42%, -40% and -31% under H0 and H1 for SPRT, TT, OPBΔ = 0.5 and OPBΔ = 0 respectively. For situations between H0 and H1, ASNs of all sequential tests were still smaller than the sample size required by SSD, with the TT displaying the largest decrease (-25%). The P90s of the TT and OPBΔ = 0 under H0 and H1 were smaller than the P90s of the SPRT and OPBΔ = 0.5, which were similar to the sample size required by SSD. If all sequential tests display approximately similar features, the TT is the most appealing regarding decreases in sample size, especially for situations between H0 and H1.
Skip Nav Destination
Article navigation
Research Article|
April 07 2000
Comparison of four sequential methods allowing for early stopping of comparative clinical trials
Véronique SEBILLE;
1Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, 2 avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France
Correspondence: Dr Véronique Sébille (e-mail [email protected]).
Search for other works by this author on:
Eric BELLISSANT
Eric BELLISSANT
1Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, 2 avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
November 08 1999
Revision Received:
December 08 1999
Accepted:
January 17 2000
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society and the Medical Research Society © 2000
2000
Clin Sci (Lond) (2000) 98 (5): 569–578.
Article history
Received:
November 08 1999
Revision Received:
December 08 1999
Accepted:
January 17 2000
Citation
Véronique SEBILLE, Eric BELLISSANT; Comparison of four sequential methods allowing for early stopping of comparative clinical trials. Clin Sci (Lond) 1 May 2000; 98 (5): 569–578. doi: https://doi.org/10.1042/cs0980569
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |